STOCK TITAN
  1. Home
  2. Financials
  3. AXSM
  4. Revenue

Axsome Therapeutics, Inc (AXSM) Revenue by Year

AXSM

Axsome Therapeutics, Inc generated $638.5M in revenue in fiscal year 2025. This represents an increase of 65.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $776.6M in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Axsome Therapeutics, Inc has filed alongside them.

FY2025 annual
Revenue $638.5M
YoY +65.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AXSM Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY21DEF 14AFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Revenue$776.6M$638.5M+65.5%$385.7M+42.5%$270.6M+440.8%$50.0MN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

AXSM Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$218.4M+45.5%$191.2M+57.4%$196.0M+65.0%$171.0M+63.2%$150.0M+72.1%$121.5M+62.0%$118.8M+66.0%$104.8M+81.3%$87.2M+86.7%$75.0M-20.7%$71.5M$57.8M+243.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Axsome Therapeutics, Inc financials

Frequently Asked Questions

What was Axsome Therapeutics, Inc's revenue in fiscal year 2025?

Axsome Therapeutics, Inc generated $638.5M in revenue in fiscal year 2025.

How fast is Axsome Therapeutics, Inc's revenue growing?

Axsome Therapeutics, Inc (AXSM) revenue rose by 65.5% year over year, from $385.7M to $638.5M in fiscal year 2025.

What is Axsome Therapeutics, Inc's revenue over the last twelve months?

Axsome Therapeutics, Inc (AXSM) reported $776.6M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Axsome Therapeutics, Inc (AXSM) reported $218.4M in revenue in Q2 2026. This represents an increase of 45.5% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Axsome Therapeutics, Inc (AXSM) reported on that line in every period on record.